UK prospective study of therapies of maturity-onset diabetes.

UK prospective study of therapies of maturity-onset diabetes.

Λεπτομέρειες βιβλιογραφικής εγγραφής
Κύριοι συγγραφείς:	Turner, R, Mann, J, Peto, R
Μορφή:	Journal article
Γλώσσα:	English
Έκδοση:	1984

Παρόμοια τεκμήρια

Relative contributions of insulin deficiency and insulin resistance in maturity-onset diabetes.
ανά: Turner, R, κ.ά.
Έκδοση: (1982)

The UK Prospective Diabetes Study. UK Prospective Diabetes Study Group.
ανά: Turner, R, κ.ά.
Έκδοση: (1996)

The UK Prospective Diabetes Study
ανά: Turner, R, κ.ά.
Έκδοση: (1996)

BETA CELL DEFICIENCY IN MATURITY ONSET DIABETES
ανά: Turner, R, κ.ά.
Έκδοση: (1976)

MATURITY-ONSET DIABETES IN YOUNG BLACK-AMERICANS
ανά: Orahilly, S, κ.ά.
Έκδοση: (1987)

UK prospective diabetes study
ανά: Turner, R, κ.ά.
Έκδοση: (1996)

The UK Prospective Diabetes Study - Reply
ανά: Turner, R, κ.ά.
Έκδοση: (1998)

Lessons from UK prospective diabetes study.
ανά: Turner, R, κ.ά.
Έκδοση: (1995)

UKPDS: what was the question? UK Prospective Diabetes Study.
ανά: Turner, R, κ.ά.
Έκδοση: (1999)

FASTING BLOOD-GLUCOSE CONCENTRATIONS AND TREATMENT OF MATURITY-ONSET DIABETES
ανά: Howedavies, S, κ.ά.
Έκδοση: (1980)

Maintenance of basal plasma glucose and insulin concentrations in maturity-onset diabetes.
ανά: Holman, R, κ.ά.
Έκδοση: (1979)

betacell function during insulin or chlorpropamide treatment of maturity-onset diabetes mellitus.
ανά: Turner, R, κ.ά.
Έκδοση: (1978)

The basal plasma glucose: a simple relevant index of maturity-onset diabetes.
ανά: Holman, R, κ.ά.
Έκδοση: (1981)

CONTROL OF MATURITY-ONSET DIABETES BY HOME OR CLINIC MONITORING OF FASTING PLASMA GLUCOSE
ανά: Howedavies, S, κ.ά.
Έκδοση: (1978)

UK prospective diabetes study
ανά: Holman, R
Έκδοση: (1990)

Non-uniform distribution of islet amyloid in the pancreas of 'maturity-onset' diabetic patients.
ανά: Clark, A, κ.ά.
Έκδοση: (1984)

STUDY DESIGN OF THE UK PROSPECTIVE DIABETES STUDY AND PROGRESS OF EYE DATA
ανά: Stratton, I, κ.ά.
Έκδοση: (1993)

PROGRESSION OF DIABETIC-RETINOPATHY IN TYPE-2 DIABETIC-PATIENTS IN THE UK PROSPECTIVE DIABETES STUDY
ανά: Stratton, I, κ.ά.
Έκδοση: (1993)

UK PROSPECTIVE DIABETES STUDY 16 - OVERVIEW OF 6 YEARS THERAPY OF TYPE-II DIABETES - A PROGRESSIVE DISEASE
ανά: Turner, R, κ.ά.
Έκδοση: (1995)

Nine-year status of diabetic retinopathy and photocoagulation in the UK prospective diabetes study.
ανά: Aldington, S, κ.ά.
Έκδοση: (1996)

Pancreatic islet amyloid and elevated proinsulin secretion in familial maturity-onset diabetes.
ανά: Clark, A, κ.ά.
Έκδοση: (1987)

UK Prospective Diabetes Study. XII: Differences between Asian, Afro-Caribbean and white Caucasian type 2 diabetic patients at diagnosis of diabetes. UK Prospective Diabetes Study Group.
ανά: Meyer, L, κ.ά.
Έκδοση: (1994)

PREVALENCE OF RETINOPATHY AT DIAGNOSIS OF TYPE-II DIABETES IN THE UK PROSPECTIVE DIABETES STUDY
ανά: Kohner, E, κ.ά.
Έκδοση: (1993)

Mature onset diabetes of the young (MODY).
ανά: E Lacerda Nobre, κ.ά.
Έκδοση: (2002-12-01)

Precision Therapy for a Chinese Family With Maturity-Onset Diabetes of the Young
ανά: Juyi Li, κ.ά.
Έκδοση: (2021-08-01)

Microaneurysms in the development of diabetic retinopathy (UKPDS 42). UK Prospective Diabetes Study Group.
ανά: Kohner, E, κ.ά.
Έκδοση: (1999)

MATURITY-ONSET DIABETES OF THE YOUNG IS A BETA-CELL DISORDER WITH NORMAL PROINSULIN LEVELS
ανά: Hattersley, A, κ.ά.
Έκδοση: (1993)

PROGRESSION OF DIABETIC-RETINOPATHY OVER 6 YEARS IN PATIENTS STUDIED IN THE UK PROSPECTIVE DIABETES STUDY
ανά: Aldington, S, κ.ά.
Έκδοση: (1994)

Maturity-Onset Diabetes of the Young Identified Among Algerian Probands with Early-Onset Diabetes
ανά: Bouldjennet F, κ.ά.
Έκδοση: (2020-12-01)

Identification of 21 novel glucokinase (GCK) mutations in UK and European Caucasians with maturity-onset diabetes of the young (MODY).
ανά: Thomson, K, κ.ά.
Έκδοση: (2003)

UK Prospective Diabetes Study (UKPDS). VIII. Study design, progress and performance.
ανά: Turner, R, κ.ά.
Έκδοση: (1991)

UKPDS 18: estimated dietary intake in type 2 diabetic patients randomly allocated to diet, sulphonylurea or insulin therapy. UK Prospective Diabetes Study Group.
ανά: Eeley, E, κ.ά.
Έκδοση: (1996)

Current views on etiology, diagnosis, epidemiology and gene therapy of maturity onset diabetes in the young
ανά: Lilya U. Dzhemileva, κ.ά.
Έκδοση: (2025-01-01)

Precision therapy for three Chinese families with maturity-onset diabetes of the young (MODY12)
ανά: Juyi Li, κ.ά.
Έκδοση: (2022-08-01)

Glycemic control with diet, sulfonylurea, metformin, or insulin in patients with type 2 diabetes mellitus: progressive requirement for multiple therapies (UKPDS 49). UK Prospective Diabetes Study (UKPDS) Group.
ανά: Turner, R, κ.ά.
Έκδοση: (1999)

Diagnosis and management of maturity onset diabetes of the young (MODY).
ανά: Thanabalasingham, G, κ.ά.
Έκδοση: (2011)

Maturity-onset diabetes of the young due to gene mutation
ανά: Hae In Lee, κ.ά.
Έκδοση: (2023-12-01)

Clinical Manifestations and Biomarkers of the Maturity-Onset Diabetes of the Young
ανά: İlhan Satman
Έκδοση: (2023-04-01)

Molecular diagnosis of maturity onset diabetes of the young in India
ανά: Veena V Nair, κ.ά.
Έκδοση: (2013-01-01)

Maturity onset diabetes of the young: Diagnosis and treatment options
ανά: Serghei Covanțev, κ.ά.
Έκδοση: (2016-12-01)